Related Experiment Video

Updated: Aug 16, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

[Sudden cardiac death: state of the art]

L V Kakturskiĭ

    Arkhiv Patologii
    |August 4, 2005
    PubMed

    Insights

    Sudden cardiac death (SCD), primarily from ischemic heart disease (IHD), occurs due to ventricular fibrillation. Reperfusion after myocardial ischemia can trigger fatal arrhythmias by releasing pro-arrhythmic substances.

    Area of Science:

    • Cardiology
    • Pathophysiology
    • Electrophysiology

    Background:

    • Sudden cardiac death (SCD) is a critical outcome of various heart conditions, with ischemic heart disease (IHD) being the leading cause.
    • Alcoholic cardiomyopathy is identified as the second most frequent cause of SCD.
    • Pathological features and risk factors for SCD align closely with those of IHD, atherosclerosis, and myocardial infarction.

    Discussion:

    • Ventricular fibrillation is the direct mechanism leading to cardiac arrest in SCD.
    • Advanced, irreversible myocardial ischemia, particularly when complicated by reperfusion, is a primary trigger for fibrillation.
    • Reperfusion facilitates the release of arrhythmogenic substances from ischemic myocardial zones, destabilizing cardiac electrical activity and causing fatal arrhythmias.

    Key Insights:

    • Ischemic heart disease is the predominant cause of sudden cardiac death.
    • Myocardial ischemia and subsequent reperfusion are critical in inducing ventricular fibrillation.
    • Understanding these mechanisms is vital for preventing fatal arrhythmias.

    Outlook:

    • Further research into the mechanisms of idiopathic ventricular fibrillation is warranted.
    • Developing targeted therapies to manage ischemia-reperfusion injury could reduce SCD incidence.
    • Investigating novel anti-arrhythmic strategies based on electrophysiological instability is crucial.

    More Related Videos

    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine05:36

    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

    Published on: January 30, 2020

    Related Concept Videos

    Introduction Cardiac Emergencies01:30

    Introduction Cardiac Emergencies

    Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
    Cardiopulmonary Resuscitation III: AED Use01:23

    Cardiopulmonary Resuscitation III: AED Use

    Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
    Acute Coronary Syndrome I: Introduction01:30

    Acute Coronary Syndrome I: Introduction

    Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
    Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

    Cardiopulmonary Resuscitation IV: Pharmacological Management

    Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
    Coronary Artery Disease III: Clinical Manifestations01:30

    Coronary Artery Disease III: Clinical Manifestations

    Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...